Posts

US Hair Transplant Procedure

US Hair Transplant Procedure

US Hair Transplant Procedure

The US Hair Transplant Procedure Market volume is expected to gain traction by reaching 231,720 by 2027 while exhibiting a CAGR of 6.1% between 2020 and 2027. Fortune Business Insights in its report, titled “US Hair Transplant Procedure Market, 2020-2027.”, observes that the market stood at 170,510 in 2019.

The rising spending capacity on cosmetic surgeries and the increasing prevalence of hair loss problems among both men and women in the U.S. is expected to favor the adoption of the product in the forthcoming years. According to the American Society of Plastic Surgeons, in 2019 around USD 16.7 billion was spent by the people in the U.S. on cosmetics procedures that included hair transplant, hair removal, ear surgery, etc.

The COVID-19 pandemic has had a seismic effect on several economies across the globe. To curb the pandemic spread, the governments of several countries have ordered a complete lockdown of industrial and human activities.

This is expected to have a significant impact on the market in 2020. However, proactive steps by the industry leaders to revive the economy will bode well for the growth of the market in the near future.

Market Segmentation:

Male Segment to Dominate; 50 Million Men Suffering from Hair Loss to Aid Growth

Based on type, this market is bifurcated into follicular hair transplantation (FUT) and follicular unit extraction (FUE). Furthermore, on the basis of age group, the market is divided into 20-29, 30-39, 40-54, and 55 & above. Based on gender, the market is classified into men and women.

  • On the basis of gender, the male segment is expected to hold the largest US Hair Transplant Procedure Market share in terms of revenue during the forecast period. This is owing to the rising number of males in the U.S. suffering from hair loss issues. For instance, in 2019, around 50 to 53 million men experienced hair loss.

What does the Report Include?

The market report includes qualitative and quantitative analysis of several factors such as the key drivers and restraints that will impact growth. Additionally, the report provides insights into the regional analysis that covers different regions, contributing to the growth of the market. It includes the competitive landscape that involves the leading companies and the adoption of strategies to announce partnerships, introduce new products, and collaborate that will further contribute to the growth of the market between 2020 and 2027.

Moreover, the research analyst has adopted several research methodologies such as SWOT and PESTEL analysis to extract information about the current trends and industry developments that will drive the market growth during the forecast period.

DRIVING FACTORS

Increasing Prevalence of Hair Loss Issues to Augment Growth

According to the International Society of Hair Restoration Surgery, around 35 million men in the U.S. experience hair loss problems, while about 21 million women are generally affected by hair loss ailments annually. The increasing incidence of hair loss among people has led to a significant advancement in hair transplantation. For instance, the growing adoption of follicular hair transplantation (FUT) and follicular unit extraction (FUE) procedures have led to an increased efficacy of the treatment. In addition to this, the procedures are quick, cause less or no discomfort to the patients, and leave less intense scarring. Therefore, the increasing prevalence of baldness and the rising spending capacity of the people for treatment solutions is anticipated to boost the US Hair Transplant Procedure Market growth during the forecast period.

COMPETITIVE LANDSCAPE

Major Companies Invest in R&D Activities to Strengthen Their Market Positions 

The market is consolidated by major companies such as Restoration Robotics, Inc., Venus Concept, and Cole Instruments Inc., among others that are striving to maintain their presence. They are doing so by investing in R&D activities to develop advanced hair transplant procedures to gain a strong footprint in the U.S. Additionally, other players are adopting organic and inorganic strategies to maintain a stronghold that will contribute to the growth of the market during the forecast period.

Industry Development

  • March 2018 – HairMax secured an approval for its HairMax Laser devices by ANVISA. The company reports that these devices are effective in treating hair loss and thinning hair problems. Also, it further aids in hair growth promotion.

 

Quick Buy US Hair Transplant Procedure Market

https://www.fortunebusinessinsights.com/checkout-page/105198

 

List of the Companies Profiled in this Market:

  • Cole Instruments Inc. (Georgia, United States)
  • CAPILLUS Inc. (Florida, United States)
  • LaserCap Company (Ohio, United States)
  • Apira Science (Florida, United States)
  • Venus Concept (Toronto, Canada)
  • THERADOME (California, United States)
  • Restoration Robotics, Inc. (California, United States)
  • Other Prominent Players

 

Get your Customized Research Report:

https://www.fortunebusinessinsights.com/enquiry/customization/u-s-hair-transplant-procedure-market-105198

 

Table Of Content

  • Introduction
    • Research Scope
    • Acronyms Section
    • Research Methodology
  • Executive Summary
  • Market Dynamics
    • Market Drivers
    • Market Restraints
  • Epidemiology Data
  • Epidemiology of Hair Loss, U.S., 2019
  • Number of Cases Suffering From Hair Loss (Millions), By Gender, 2019
  • Prevalence of Hair Loss (%), By Gender, 2019
  • Prevalence of Noticeable Hair Loss, By Age and Gender, U.S., 2019
  • Impact of COVID-19 on Hair Transplant Procedure Market
    • Major Factors
    • Steps Taken to Minimize the Impact of COVID-19 in Hair Transplant Industry
    • Opportunities offered by COVID-19 – Hair Transplant Industry
    • U.S. COVID-19 Impact on Hair Transplant Procedure Market Size, 2019-2021
  • U.S. Hair Transplant Procedure Volume
    • U.S. Hair Transplant Procedure Volume, Forecast and Analysis, 2016-2027
    • Distribution of Hair Transplant Procedure in the U.S.
    • By Age Group
    • By Gender
    • By Procedure Type
  • New Product/Procedure Developments and Company Analysis
  • Robotic Hair Transplant
  • NeoGraft Technique
  • Hair Stimulating Complex (HSC)
  • Hair Stem Cell Transplantation

US Hair Transplant Procedure

Source

Recent Posts

US Hair Transplant Procedure

US Hair Transplant Procedure

US Hair Transplant Procedure

US Hair Transplant Procedure

The US Hair Transplant Procedure Market volume is expected to gain traction by reaching 231,720 by 2027 while exhibiting a CAGR of 6.1% between 2020 and 2027. Fortune Business Insights in its report, titled “US Hair Transplant Procedure Market, 2020-2027.”, observes that the market stood at 170,510 in 2019.

The rising spending capacity on cosmetic surgeries and the increasing prevalence of hair loss problems among both men and women in the U.S. is expected to favor the adoption of the product in the forthcoming years. According to the American Society of Plastic Surgeons, in 2019 around USD 16.7 billion was spent by the people in the U.S. on cosmetics procedures that included hair transplant, hair removal, ear surgery, etc.

The COVID-19 pandemic has had a seismic effect on several economies across the globe. To curb the pandemic spread, the governments of several countries have ordered a complete lockdown of industrial and human activities.

This is expected to have a significant impact on the market in 2020. However, proactive steps by the industry leaders to revive the economy will bode well for the growth of the market in the near future.

Market Segmentation:

Male Segment to Dominate; 50 Million Men Suffering from Hair Loss to Aid Growth

Based on type, this market is bifurcated into follicular hair transplantation (FUT) and follicular unit extraction (FUE). Furthermore, on the basis of age group, the market is divided into 20-29, 30-39, 40-54, and 55 & above. Based on gender, the market is classified into men and women.

  • On the basis of gender, the male segment is expected to hold the largest US Hair Transplant Procedure Market share in terms of revenue during the forecast period. This is owing to the rising number of males in the U.S. suffering from hair loss issues. For instance, in 2019, around 50 to 53 million men experienced hair loss.

What does the Report Include?

The market report includes qualitative and quantitative analysis of several factors such as the key drivers and restraints that will impact growth. Additionally, the report provides insights into the regional analysis that covers different regions, contributing to the growth of the market. It includes the competitive landscape that involves the leading companies and the adoption of strategies to announce partnerships, introduce new products, and collaborate that will further contribute to the growth of the market between 2020 and 2027.

Moreover, the research analyst has adopted several research methodologies such as SWOT and PESTEL analysis to extract information about the current trends and industry developments that will drive the market growth during the forecast period.

DRIVING FACTORS

Increasing Prevalence of Hair Loss Issues to Augment Growth

According to the International Society of Hair Restoration Surgery, around 35 million men in the U.S. experience hair loss problems, while about 21 million women are generally affected by hair loss ailments annually. The increasing incidence of hair loss among people has led to a significant advancement in hair transplantation. For instance, the growing adoption of follicular hair transplantation (FUT) and follicular unit extraction (FUE) procedures have led to an increased efficacy of the treatment. In addition to this, the procedures are quick, cause less or no discomfort to the patients, and leave less intense scarring. Therefore, the increasing prevalence of baldness and the rising spending capacity of the people for treatment solutions is anticipated to boost the US Hair Transplant Procedure Market growth during the forecast period.

COMPETITIVE LANDSCAPE

Major Companies Invest in R&D Activities to Strengthen Their Market Positions 

The market is consolidated by major companies such as Restoration Robotics, Inc., Venus Concept, and Cole Instruments Inc., among others that are striving to maintain their presence. They are doing so by investing in R&D activities to develop advanced hair transplant procedures to gain a strong footprint in the U.S. Additionally, other players are adopting organic and inorganic strategies to maintain a stronghold that will contribute to the growth of the market during the forecast period.

Industry Development

  • March 2018 – HairMax secured an approval for its HairMax Laser devices by ANVISA. The company reports that these devices are effective in treating hair loss and thinning hair problems. Also, it further aids in hair growth promotion.

 

Quick Buy US Hair Transplant Procedure Market

https://www.fortunebusinessinsights.com/checkout-page/105198

 

List of the Companies Profiled in this Market:

  • Cole Instruments Inc. (Georgia, United States)
  • CAPILLUS Inc. (Florida, United States)
  • LaserCap Company (Ohio, United States)
  • Apira Science (Florida, United States)
  • Venus Concept (Toronto, Canada)
  • THERADOME (California, United States)
  • Restoration Robotics, Inc. (California, United States)
  • Other Prominent Players

 

Get your Customized Research Report:

https://www.fortunebusinessinsights.com/enquiry/customization/u-s-hair-transplant-procedure-market-105198

 

Table Of Content

  • Introduction
    • Research Scope
    • Acronyms Section
    • Research Methodology
  • Executive Summary
  • Market Dynamics
    • Market Drivers
    • Market Restraints
  • Epidemiology Data
  • Epidemiology of Hair Loss, U.S., 2019
  • Number of Cases Suffering From Hair Loss (Millions), By Gender, 2019
  • Prevalence of Hair Loss (%), By Gender, 2019
  • Prevalence of Noticeable Hair Loss, By Age and Gender, U.S., 2019
  • Impact of COVID-19 on Hair Transplant Procedure Market
    • Major Factors
    • Steps Taken to Minimize the Impact of COVID-19 in Hair Transplant Industry
    • Opportunities offered by COVID-19 – Hair Transplant Industry
    • U.S. COVID-19 Impact on Hair Transplant Procedure Market Size, 2019-2021
  • U.S. Hair Transplant Procedure Volume
    • U.S. Hair Transplant Procedure Volume, Forecast and Analysis, 2016-2027
    • Distribution of Hair Transplant Procedure in the U.S.
    • By Age Group
    • By Gender
    • By Procedure Type
  • New Product/Procedure Developments and Company Analysis
  • Robotic Hair Transplant
  • NeoGraft Technique
  • Hair Stimulating Complex (HSC)
  • Hair Stem Cell Transplantation

US Hair Transplant Procedure

Source

Recent Posts

US Hair Transplant Procedure

Alopecia Therapeutics Industry Analysis

Alopecia Therapeutics Industry Analysis

Androgenic Alopecia Therapeutics Industry Analysis, Market Size, Share, Trends, Growth and Forecast 2021 – 2029

Key Companies

Johnson & Johnson Merck GlaxoSmithKline Astellas Pharma Cipla Almirall Sun Pharma Reddy’s Laboratories Concert Pharmaceuticals RiverTown Therapeutics Brickell Biotech BiologicsMD Aclaris

Therapeutics Segmentation Covered By Type

Medicine Surgery By Application Hospital Clinic By Region :

Asia-Pacific: China, Southeast Asia, India, Japan, Korea, Oceania Europe : Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland North America : United States, Canada, Mexico Middle East & Africa : GCC, North Africa, South Africa South America : Brazil, Argentina, Columbia, Chile, Peru

Table of content

Chapter 1 Global Androgenic Alopecia Therapeutics Market Overview

1.1 Introduction
1.2 Taxonomy
1.2.1 By Product Type & End User
1.2.2 By Region
1.3 Drivers for Androgenic Alopecia Therapeutics Market
1.4 Restraints for Androgenic Alopecia Therapeutics Market
1.5 Opportunities for Androgenic Alopecia Therapeutics Market
1.6 Trends for Androgenic Alopecia Therapeutics Market
1.7 COVID-19 Impact Assessment on Androgenic Alopecia Therapeutics Industry
1.8 Macro-economic Factors
1.9 Regulatory Framework
1.10 Pricing Analysis by Region, 2020
1.11 Opportunity Map Analysis
1.12 Opportunity Orbits
1.13 Market Investment Feasibility Index
1.14 PEST Analysis
1.15 PORTERS Five Force Analysis
1.16 Go to Market Strategy
1.17 Value Chain Analysis
1.18 Cost Structure Analysis
1.19 Regional Market Share and BPS Analysis

Chapter 2

Table of content

Chapter 1 Global Androgenic Alopecia Therapeutics Market Overview
1.1 Introduction
1.2 Taxonomy
1.2.1 By Product Type & End User
1.2.2 By Region
1.3 Drivers for Androgenic Alopecia Therapeutics Market
1.4 Restraints for Androgenic Alopecia Therapeutics Market
1.5 Opportunities for Androgenic Alopecia Therapeutics Market
1.6 Trends for Androgenic Alopecia Therapeutics Market
1.7 COVID-19 Impact Assessment on Androgenic Alopecia Therapeutics Industry
1.8 Macro-economic Factors
1.9 Regulatory Framework
1.10 Pricing Analysis by Region, 2020
1.11 Opportunity Map Analysis
1.12 Opportunity Orbits
1.13 Market Investment Feasibility Index
1.14 PEST Analysis
1.15 PORTERS Five Force Analysis
1.16 Go to Market Strategy
1.17 Value Chain Analysis
1.18 Cost Structure Analysis
1.19 Regional Market Share and BPS Analysis

Chapter 2 Global Androgenic Alopecia Therapeutics Market Overview
2.1 Global Androgenic Alopecia Therapeutics Market by Product Type
2.1.1 Global Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2029)
2.1.2 Global Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Market Share by Product Type in 2019
2.1.3 Global Androgenic Alopecia Therapeutics Market Attractiveness Analysis by Product Type, (2013-2020)
2.2 Global Androgenic Alopecia Therapeutics Market by End User
2.2.1 Global Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2029)
2.2.2 Global Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Market Share by End User in 2019
2.2.3 Global Androgenic Alopecia Therapeutics Market Attractiveness Analysis by End User, (2013-2020)
2.3 Global Androgenic Alopecia Therapeutics Market by Region
2.3.1 Global Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2029)
2.3.2 Global Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Market Share by Region in 2019
2.3.3 Global Androgenic Alopecia Therapeutics Market Attractiveness Analysis by Region, (2013-2020)
2.4 Global Androgenic Alopecia Therapeutics Market Outlook (2013-2029)
2.4.1 Global Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) (2013-2020)
2.4.2 Global Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) (2021-2029)
2.5 Global Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) by Regions
2.5.1 Global Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2020)
2.5.2 Global Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by Region (2021-2029)
2.6 Global Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) by Product Type
2.6.1 Global Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2020)
2.6.2 Global Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2021-2029)
2.7 Global Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) by End User
2.7.1 Global Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2020)
2.7.2 Global Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by End User (2021-2029)
2.8 Global Androgenic Alopecia Therapeutics Market Y-o-Y Growth Rate Comparison (2014-2029)
2.8.1 Global Androgenic Alopecia Therapeutics Market Y-o-Y Growth Rate by Region
2.8.2 Global Androgenic Alopecia Therapeutics Market Y-o-Y Growth Rate by Product Type
2.8.3 Global Androgenic Alopecia Therapeutics Market Y-o-Y Growth Rate by End User
2.9 Global Androgenic Alopecia Therapeutics Market Share Comparison (2013-2029)
2.9.1 Global Androgenic Alopecia Therapeutics Market Share by Region
2.9.2 Global Androgenic Alopecia Therapeutics Market Share by Product Type
2.9.3 Global Androgenic Alopecia Therapeutics Market Share by End User

Chapter 3 North America Androgenic Alopecia Therapeutics Market Overview
3.1 North America Androgenic Alopecia Therapeutics Market by Product Type
3.1.1 North America Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2029)
3.1.2 North America Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Market Share by Product Type in 2019
3.1.3 North America Androgenic Alopecia Therapeutics Market Attractiveness Analysis by Product Type, (2013-2020)
3.2 North America Androgenic Alopecia Therapeutics Market by End User
3.2.1 North America Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2029)
3.2.2 North America Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Market Share by End User in 2019
3.2.3 North America Androgenic Alopecia Therapeutics Market Attractiveness Analysis by End User, (2013-2020)
3.3 North America Androgenic Alopecia Therapeutics Market by Region
3.3.1 North America Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2029)
3.3.2 North America Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Market Share by Region in 2019
3.3.3 North America Androgenic Alopecia Therapeutics Market Attractiveness Analysis by Region, (2013-2020)
3.4 North America Androgenic Alopecia Therapeutics Market Outlook (2013-2029)
3.4.1 North America Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) (2013-2020)
3.4.2 North America Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) (2021-2029)
3.5 North America Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) by Regions
3.5.1 North America Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2020)
3.5.2 North America Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by Region (2021-2029)
3.6 North America Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) by Product Type
3.6.1 North America Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2020)
3.6.2 North America Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2021-2029)
3.7 North America Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) by End User
3.7.1 North America Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2020)
3.7.2 North America Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by End User (2021-2029)
3.8 North America Androgenic Alopecia Therapeutics Market Y-o-Y Growth Rate Comparison (2014-2029)
3.8.1 North America Androgenic Alopecia Therapeutics Market Y-o-Y Growth Rate by Region
3.8.2 North America Androgenic Alopecia Therapeutics Market Y-o-Y Growth Rate by Product Type
3.8.3 North America Androgenic Alopecia Therapeutics Market Y-o-Y Growth Rate by End User
3.9 North America Androgenic Alopecia Therapeutics Market Share Comparison (2013-2029)
3.9.1 North America Androgenic Alopecia Therapeutics Market Share by Region
3.9.2 North America Androgenic Alopecia Therapeutics Market Share by Product Type
3.9.3 North America Androgenic Alopecia Therapeutics Market Share by End User

Chapter 4 Europe Androgenic Alopecia Therapeutics Market Overview
4.1 Europe Androgenic Alopecia Therapeutics Market by Product Type
4.1.1 Europe Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2029)
4.1.2 Europe Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Market Share by Product Type in 2019
4.1.3 Europe Androgenic Alopecia Therapeutics Market Attractiveness Analysis by Product Type, (2013-2020)
4.2 Europe Androgenic Alopecia Therapeutics Market by End User
4.2.1 Europe Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2029)
4.2.2 Europe Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Market Share by End User in 2019
4.2.3 Europe Androgenic Alopecia Therapeutics Market Attractiveness Analysis by End User, (2013-2020)
4.3 Europe Androgenic Alopecia Therapeutics Market by Region
4.3.1 Europe Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2029)
4.3.2 Europe Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Market Share by Region in 2019
4.3.3 Europe Androgenic Alopecia Therapeutics Market Attractiveness Analysis by Region, (2013-2020)
4.4 Europe Androgenic Alopecia Therapeutics Market Outlook (2013-2029)
4.4.1 Europe Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) (2013-2020)
4.4.2 Europe Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) (2021-2029)
4.5 Europe Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) by Regions
4.5.1 Europe Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2020)
4.5.2 Europe Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by Region (2021-2029)
4.6 Europe Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) by Product Type
4.6.1 Europe Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2020)
4.6.2 Europe Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2021-2029)
4.7 Europe Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) by End User
4.7.1 Europe Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2020)
4.7.2 Europe Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by End User (2021-2029)
4.8 Europe Androgenic Alopecia Therapeutics Market Y-o-Y Growth Rate Comparison (2014-2029)
4.8.1 Europe Androgenic Alopecia Therapeutics Market Y-o-Y Growth Rate by Region
4.8.2 Europe Androgenic Alopecia Therapeutics Market Y-o-Y Growth Rate by Product Type
4.8.3 Europe Androgenic Alopecia Therapeutics Market Y-o-Y Growth Rate by End User
4.9 Europe Androgenic Alopecia Therapeutics Market Share Comparison (2013-2029)
4.9.1 Europe Androgenic Alopecia Therapeutics Market Share by Region
4.9.2 Europe Androgenic Alopecia Therapeutics Market Share by Product Type
4.9.3 Europe Androgenic Alopecia Therapeutics Market Share by End User

Chapter 5 Asia Pacific Androgenic Alopecia Therapeutics Market Overview
5.1 Asia Pacific Androgenic Alopecia Therapeutics Market by Product Type
5.1.1 Asia Pacific Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2029)
5.1.2 Asia Pacific Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Market Share by Product Type in 2019
5.1.3 Asia Pacific Androgenic Alopecia Therapeutics Market Attractiveness Analysis by Product Type, (2013-2020)
5.2 Asia Pacific Androgenic Alopecia Therapeutics Market by End User
5.2.1 Asia Pacific Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2029)
5.2.2 Asia Pacific Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Market Share by End User in 2019
5.2.3 Asia Pacific Androgenic Alopecia Therapeutics Market Attractiveness Analysis by End User, (2013-2020)
5.3 Asia Pacific Androgenic Alopecia Therapeutics Market by Region
5.3.1 Asia Pacific Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2029)
5.3.2 Asia Pacific Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Market Share by Region in 2019
5.3.3 Asia Pacific Androgenic Alopecia Therapeutics Market Attractiveness Analysis by Region, (2013-2020)
5.4 Asia Pacific Androgenic Alopecia Therapeutics Market Outlook (2013-2029)
5.4.1 Asia Pacific Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) (2013-2020)
5.4.2 Asia Pacific Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) (2021-2029)
5.5 Asia Pacific Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) by Regions
5.5.1 Asia Pacific Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2020)
5.5.2 Asia Pacific Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by Region (2021-2029)
5.6 Asia Pacific Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) by Product Type
5.6.1 Asia Pacific Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2020)
5.6.2 Asia Pacific Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2021-2029)
5.7 Asia Pacific Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) by End User
5.7.1 Asia Pacific Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2020)
5.7.2 Asia Pacific Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by End User (2021-2029)
5.8 Asia Pacific Androgenic Alopecia Therapeutics Market Y-o-Y Growth Rate Comparison (2014-2029)
5.8.1 Asia Pacific Androgenic Alopecia Therapeutics Market Y-o-Y Growth Rate by Region
5.8.2 Asia Pacific Androgenic Alopecia Therapeutics Market Y-o-Y Growth Rate by Product Type
5.8.3 Asia Pacific Androgenic Alopecia Therapeutics Market Y-o-Y Growth Rate by End User
5.9 Asia Pacific Androgenic Alopecia Therapeutics Market Share Comparison (2013-2029)
5.9.1 Asia Pacific Androgenic Alopecia Therapeutics Market Share by Region
5.9.2 Asia Pacific Androgenic Alopecia Therapeutics Market Share by Product Type
5.9.3 Asia Pacific Androgenic Alopecia Therapeutics Market Share by End User

Chapter 6 South America Androgenic Alopecia Therapeutics Market Overview
6.1 South America Androgenic Alopecia Therapeutics Market by Product Type
6.1.1 South America Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2029)
6.1.2 South America Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Market Share by Product Type in 2019
6.1.3 South America Androgenic Alopecia Therapeutics Market Attractiveness Analysis by Product Type, (2013-2020)
6.2 South America Androgenic Alopecia Therapeutics Market by End User
6.2.1 South America Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2029)
6.2.2 South America Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Market Share by End User in 2019
6.2.3 South America Androgenic Alopecia Therapeutics Market Attractiveness Analysis by End User, (2013-2020)
6.3 South America Androgenic Alopecia Therapeutics Market by Region
6.3.1 South America Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2029)
6.3.2 South America Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Market Share by Region in 2019
6.3.3 South America Androgenic Alopecia Therapeutics Market Attractiveness Analysis by Region, (2013-2020)
6.4 South America Androgenic Alopecia Therapeutics Market Outlook (2013-2029)
6.4.1 South America Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) (2013-2020)
6.4.2 South America Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) (2021-2029)
6.5 South America Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) by Regions
6.5.1 South America Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2020)
6.5.2 South America Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by Region (2021-2029)
6.6 South America Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) by Product Type
6.6.1 South America Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2020)
6.6.2 South America Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2021-2029)
6.7 South America Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) by End User
6.7.1 South America Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2020)
6.7.2 South America Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by End User (2021-2029)
6.8 South America Androgenic Alopecia Therapeutics Market Y-o-Y Growth Rate Comparison (2014-2029)
6.8.1 South America Androgenic Alopecia Therapeutics Market Y-o-Y Growth Rate by Region
6.8.2 South America Androgenic Alopecia Therapeutics Market Y-o-Y Growth Rate by Product Type
6.8.3 South America Androgenic Alopecia Therapeutics Market Y-o-Y Growth Rate by End User
6.9 South America Androgenic Alopecia Therapeutics Market Share Comparison 2013-2029
6.9.1 South America Androgenic Alopecia Therapeutics Market Share by Region
6.9.2 South America Androgenic Alopecia Therapeutics Market Share by Product Type
6.9.3 South America Androgenic Alopecia Therapeutics Market Share by End User

Chapter 7 MEA Androgenic Alopecia Therapeutics Market Overview
7.1 MEA Androgenic Alopecia Therapeutics Market by Product Type
7.1.1 MEA Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2029)
7.1.2 MEA Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Market Share by Product Type in 2019
7.1.3 MEA Androgenic Alopecia Therapeutics Market Attractiveness Analysis by Product Type, (2013-2020)
7.2 MEA Androgenic Alopecia Therapeutics Market by End User
7.2.1 MEA Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2029)
7.2.2 MEA Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Market Share by End User in 2019
7.2.3 MEA Androgenic Alopecia Therapeutics Market Attractiveness Analysis by End User, (2013-2020)
7.3 MEA Androgenic Alopecia Therapeutics Market by Region
7.3.1 MEA Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2029)
7.3.2 MEA Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Market Share by Region in 2019
7.3.3 MEA Androgenic Alopecia Therapeutics Market Attractiveness Analysis by Region, (2013-2020)
7.4 MEA Androgenic Alopecia Therapeutics Market Outlook (2013-2029)
7.4.1 MEA Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) (2013-2020)
7.4.2 MEA Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) (2021-2029)
7.5 MEA Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) by Regions
7.5.1 MEA Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2020)
7.5.2 MEA Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by Region (2021-2029)
7.6 MEA Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) by Product Type
7.6.1 MEA Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2020)
7.6.2 MEA Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2021-2029)
7.7 MEA Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) by End User
7.7.1 MEA Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2020)
7.7.2 MEA Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by End User (2021-2029)
7.8 MEA Androgenic Alopecia Therapeutics Market Y-o-Y Growth Rate Comparison (2014-2029)
7.8.1 MEA Androgenic Alopecia Therapeutics Market Y-o-Y Growth Rate by Region
7.8.2 MEA Androgenic Alopecia Therapeutics Market Y-o-Y Growth Rate by Product Type
7.8.3 MEA Androgenic Alopecia Therapeutics Market Y-o-Y Growth Rate by End User
7.9 MEA Androgenic Alopecia Therapeutics Market Share Comparison (2013-2029)
7.9.1 MEA Androgenic Alopecia Therapeutics Market Share by Region
7.9.2 MEA Androgenic Alopecia Therapeutics Market Share by Product Type
7.9.3 MEA Androgenic Alopecia Therapeutics Market Share by End User

Chapter 8 Global Androgenic Alopecia Therapeutics Market Company Profiles
8.1 Market Competition Scenario Analysis, By Company
8.2 Competitor Landscape
8.3 Company Share Analysis
8.4 Company Profiles
8.4.1 Company
8.4.1.1 Company Overview
8.4.1.2 Business Description
8.4.1.3 Product Portfolio
8.4.1.4 Key Financials
8.4.1.5 Key Developments
8.4.1.6 SWOT Analysis

Companies Included :
Johnson & Johnson
Merck
GlaxoSmithKline
Astellas Pharma
Cipla
Almirall
Sun Pharma
Reddy’s Laboratories
Concert Pharmaceuticals
RiverTown Therapeutics
Brickell Biotech
BiologicsMD
Aclaris Therapeutics

Chapter 9 Methodology and Data Source
9.1 Research Approach/ Methodology
9.2 Market Size Estimation
9.3 Market Breakdown and Data Triangulation
9.4 Data Source
9.4.1 Secondary Sources
9.4.2 Primary Sources

 

2.1 Global Androgenic Alopecia Therapeutics Market by Product Type
2.1.1 Global Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2029)
2.1.2 Global Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Market Share by Product Type in 2019
2.1.3 Global Androgenic Alopecia Therapeutics Market Attractiveness Analysis by Product Type, (2013-2020)
2.2 Global Androgenic Alopecia Therapeutics Market by End User
2.2.1 Global Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2029)
2.2.2 Global Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Market Share by End User in 2019
2.2.3 Global Androgenic Alopecia Therapeutics Market Attractiveness Analysis by End User, (2013-2020)
2.3 Global Androgenic Alopecia Therapeutics Market by Region
2.3.1 Global Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2029)
2.3.2 Global Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Market Share by Region in 2019
2.3.3 Global Androgenic Alopecia Therapeutics Market Attractiveness Analysis by Region, (2013-2020)
2.4 Global Androgenic Alopecia Therapeutics Market Outlook (2013-2029)
2.4.1 Global Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) (2013-2020)
2.4.2 Global Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) (2021-2029)
2.5 Global Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) by Regions
2.5.1 Global Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2020)
2.5.2 Global Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by Region (2021-2029)
2.6 Global Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) by Product Type
2.6.1 Global Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2020)
2.6.2 Global Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2021-2029)
2.7 Global Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) by End User
2.7.1 Global Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2020)
2.7.2 Global Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by End User (2021-2029)
2.8 Global Androgenic Alopecia Therapeutics Market Y-o-Y Growth Rate Comparison (2014-2029)
2.8.1 Global Androgenic Alopecia Therapeutics Market Y-o-Y Growth Rate by Region
2.8.2 Global Androgenic Alopecia Therapeutics Market Y-o-Y Growth Rate by Product Type
2.8.3 Global Androgenic Alopecia Therapeutics Market Y-o-Y Growth Rate by End User
2.9 Global Androgenic Alopecia Therapeutics Market Share Comparison (2013-2029)
2.9.1 Global Androgenic Alopecia Therapeutics Market Share by Region
2.9.2 Global Androgenic Alopecia Therapeutics Market Share by Product Type
2.9.3 Global Androgenic Alopecia Therapeutics Market Share by End User

Chapter 3 North America Androgenic Alopecia Therapeutics Market Overview

3.1 North America Androgenic Alopecia Therapeutics Market by Product Type
3.1.1 North America Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2029)
3.1.2 North America Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Market Share by Product Type in 2019
3.1.3 North America Androgenic Alopecia Therapeutics Market Attractiveness Analysis by Product Type, (2013-2020)
3.2 North America Androgenic Alopecia Therapeutics Market by End User
3.2.1 North America Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2029)
3.2.2 North America Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Market Share by End User in 2019
3.2.3 North America Androgenic Alopecia Therapeutics Market Attractiveness Analysis by End User, (2013-2020)
3.3 North America Androgenic Alopecia Therapeutics Market by Region
3.3.1 North America Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2029)
3.3.2 North America Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Market Share by Region in 2019
3.3.3 North America Androgenic Alopecia Therapeutics Market Attractiveness Analysis by Region, (2013-2020)
3.4 North America Androgenic Alopecia Therapeutics Market Outlook (2013-2029)
3.4.1 North America Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) (2013-2020)
3.4.2 North America Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) (2021-2029)
3.5 North America Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) by Regions
3.5.1 North America Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2020)
3.5.2 North America Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by Region (2021-2029)
3.6 North America Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) by Product Type
3.6.1 North America Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2020)
3.6.2 North America Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2021-2029)
3.7 North America Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) by End User
3.7.1 North America Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2020)
3.7.2 North America Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by End User (2021-2029)
3.8 North America Androgenic Alopecia Therapeutics Market Y-o-Y Growth Rate Comparison (2014-2029)
3.8.1 North America Androgenic Alopecia Therapeutics Market Y-o-Y Growth Rate by Region
3.8.2 North America Androgenic Alopecia Therapeutics Market Y-o-Y Growth Rate by Product Type
3.8.3 North America Androgenic Alopecia Therapeutics Market Y-o-Y Growth Rate by End User
3.9 North America Androgenic Alopecia Therapeutics Market Share Comparison (2013-2029)
3.9.1 North America Androgenic Alopecia Therapeutics Market Share by Region
3.9.2 North America Androgenic Alopecia Therapeutics Market Share by Product Type
3.9.3 North America Androgenic Alopecia Therapeutics Market Share by End User

Chapter 4 Europe Androgenic Alopecia Therapeutics Market Overview

4.1 Europe Androgenic Alopecia Therapeutics Market by Product Type
4.1.1 Europe Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2029)
4.1.2 Europe Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Market Share by Product Type in 2019
4.1.3 Europe Androgenic Alopecia Therapeutics Market Attractiveness Analysis by Product Type, (2013-2020)
4.2 Europe Androgenic Alopecia Therapeutics Market by End User
4.2.1 Europe Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2029)
4.2.2 Europe Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Market Share by End User in 2019
4.2.3 Europe Androgenic Alopecia Therapeutics Market Attractiveness Analysis by End User, (2013-2020)
4.3 Europe Androgenic Alopecia Therapeutics Market by Region
4.3.1 Europe Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2029)
4.3.2 Europe Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Market Share by Region in 2019
4.3.3 Europe Androgenic Alopecia Therapeutics Market Attractiveness Analysis by Region, (2013-2020)
4.4 Europe Androgenic Alopecia Therapeutics Market Outlook (2013-2029)
4.4.1 Europe Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) (2013-2020)
4.4.2 Europe Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) (2021-2029)
4.5 Europe Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) by Regions
4.5.1 Europe Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2020)
4.5.2 Europe Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by Region (2021-2029)
4.6 Europe Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) by Product Type
4.6.1 Europe Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2020)
4.6.2 Europe Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2021-2029)
4.7 Europe Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) by End User
4.7.1 Europe Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2020)
4.7.2 Europe Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by End User (2021-2029)
4.8 Europe Androgenic Alopecia Therapeutics Market Y-o-Y Growth Rate Comparison (2014-2029)
4.8.1 Europe Androgenic Alopecia Therapeutics Market Y-o-Y Growth Rate by Region
4.8.2 Europe Androgenic Alopecia Therapeutics Market Y-o-Y Growth Rate by Product Type
4.8.3 Europe Androgenic Alopecia Therapeutics Market Y-o-Y Growth Rate by End User
4.9 Europe Androgenic Alopecia Therapeutics Market Share Comparison (2013-2029)
4.9.1 Europe Androgenic Alopecia Therapeutics Market Share by Region
4.9.2 Europe Androgenic Alopecia Therapeutics Market Share by Product Type
4.9.3 Europe Androgenic Alopecia Therapeutics Market Share by End User

Chapter 5 Asia Pacific Androgenic Alopecia Therapeutics Market Overview

5.1 Asia Pacific Androgenic Alopecia Therapeutics Market by Product Type
5.1.1 Asia Pacific Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2029)
5.1.2 Asia Pacific Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Market Share by Product Type in 2019
5.1.3 Asia Pacific Androgenic Alopecia Therapeutics Market Attractiveness Analysis by Product Type, (2013-2020)
5.2 Asia Pacific Androgenic Alopecia Therapeutics Market by End User
5.2.1 Asia Pacific Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2029)
5.2.2 Asia Pacific Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Market Share by End User in 2019
5.2.3 Asia Pacific Androgenic Alopecia Therapeutics Market Attractiveness Analysis by End User, (2013-2020)
5.3 Asia Pacific Androgenic Alopecia Therapeutics Market by Region
5.3.1 Asia Pacific Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2029)
5.3.2 Asia Pacific Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Market Share by Region in 2019
5.3.3 Asia Pacific Androgenic Alopecia Therapeutics Market Attractiveness Analysis by Region, (2013-2020)
5.4 Asia Pacific Androgenic Alopecia Therapeutics Market Outlook (2013-2029)
5.4.1 Asia Pacific Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) (2013-2020)
5.4.2 Asia Pacific Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) (2021-2029)
5.5 Asia Pacific Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) by Regions
5.5.1 Asia Pacific Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2020)
5.5.2 Asia Pacific Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by Region (2021-2029)
5.6 Asia Pacific Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) by Product Type
5.6.1 Asia Pacific Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2020)
5.6.2 Asia Pacific Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2021-2029)
5.7 Asia Pacific Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) by End User
5.7.1 Asia Pacific Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2020)
5.7.2 Asia Pacific Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by End User (2021-2029)
5.8 Asia Pacific Androgenic Alopecia Therapeutics Market Y-o-Y Growth Rate Comparison (2014-2029)
5.8.1 Asia Pacific Androgenic Alopecia Therapeutics Market Y-o-Y Growth Rate by Region
5.8.2 Asia Pacific Androgenic Alopecia Therapeutics Market Y-o-Y Growth Rate by Product Type
5.8.3 Asia Pacific Androgenic Alopecia Therapeutics Market Y-o-Y Growth Rate by End User
5.9 Asia Pacific Androgenic Alopecia Therapeutics Market Share Comparison (2013-2029)
5.9.1 Asia Pacific Androgenic Alopecia Therapeutics Market Share by Region
5.9.2 Asia Pacific Androgenic Alopecia Therapeutics Market Share by Product Type
5.9.3 Asia Pacific Androgenic Alopecia Therapeutics Market Share by End User

Chapter 6 South America Androgenic Alopecia Therapeutics Market Overview

6.1 South America Androgenic Alopecia Therapeutics Market by Product Type
6.1.1 South America Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2029)
6.1.2 South America Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Market Share by Product Type in 2019
6.1.3 South America Androgenic Alopecia Therapeutics Market Attractiveness Analysis by Product Type, (2013-2020)
6.2 South America Androgenic Alopecia Therapeutics Market by End User
6.2.1 South America Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2029)
6.2.2 South America Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Market Share by End User in 2019
6.2.3 South America Androgenic Alopecia Therapeutics Market Attractiveness Analysis by End User, (2013-2020)
6.3 South America Androgenic Alopecia Therapeutics Market by Region
6.3.1 South America Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2029)
6.3.2 South America Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Market Share by Region in 2019
6.3.3 South America Androgenic Alopecia Therapeutics Market Attractiveness Analysis by Region, (2013-2020)
6.4 South America Androgenic Alopecia Therapeutics Market Outlook (2013-2029)
6.4.1 South America Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) (2013-2020)
6.4.2 South America Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) (2021-2029)
6.5 South America Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) by Regions
6.5.1 South America Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2020)
6.5.2 South America Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by Region (2021-2029)
6.6 South America Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) by Product Type
6.6.1 South America Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2020)
6.6.2 South America Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2021-2029)
6.7 South America Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) by End User
6.7.1 South America Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2020)
6.7.2 South America Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by End User (2021-2029)
6.8 South America Androgenic Alopecia Therapeutics Market Y-o-Y Growth Rate Comparison (2014-2029)
6.8.1 South America Androgenic Alopecia Therapeutics Market Y-o-Y Growth Rate by Region
6.8.2 South America Androgenic Alopecia Therapeutics Market Y-o-Y Growth Rate by Product Type
6.8.3 South America Androgenic Alopecia Therapeutics Market Y-o-Y Growth Rate by End User
6.9 South America Androgenic Alopecia Therapeutics Market Share Comparison 2013-2029
6.9.1 South America Androgenic Alopecia Therapeutics Market Share by Region
6.9.2 South America Androgenic Alopecia Therapeutics Market Share by Product Type
6.9.3 South America Androgenic Alopecia Therapeutics Market Share by End User

Chapter 7 MEA Androgenic Alopecia Therapeutics Market Overview

7.1 MEA Androgenic Alopecia Therapeutics Market by Product Type
7.1.1 MEA Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2029)
7.1.2 MEA Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Market Share by Product Type in 2019
7.1.3 MEA Androgenic Alopecia Therapeutics Market Attractiveness Analysis by Product Type, (2013-2020)
7.2 MEA Androgenic Alopecia Therapeutics Market by End User
7.2.1 MEA Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2029)
7.2.2 MEA Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Market Share by End User in 2019
7.2.3 MEA Androgenic Alopecia Therapeutics Market Attractiveness Analysis by End User, (2013-2020)
7.3 MEA Androgenic Alopecia Therapeutics Market by Region
7.3.1 MEA Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2029)
7.3.2 MEA Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Market Share by Region in 2019
7.3.3 MEA Androgenic Alopecia Therapeutics Market Attractiveness Analysis by Region, (2013-2020)
7.4 MEA Androgenic Alopecia Therapeutics Market Outlook (2013-2029)
7.4.1 MEA Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) (2013-2020)
7.4.2 MEA Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) (2021-2029)
7.5 MEA Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) by Regions
7.5.1 MEA Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2020)
7.5.2 MEA Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by Region (2021-2029)
7.6 MEA Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) by Product Type
7.6.1 MEA Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2020)
7.6.2 MEA Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2021-2029)
7.7 MEA Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) by End User
7.7.1 MEA Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2020)
7.7.2 MEA Androgenic Alopecia Therapeutics Market Value (US$ Mn) and Volume (Units) Comparison by End User (2021-2029)
7.8 MEA Androgenic Alopecia Therapeutics Market Y-o-Y Growth Rate Comparison (2014-2029)
7.8.1 MEA Androgenic Alopecia Therapeutics Market Y-o-Y Growth Rate by Region
7.8.2 MEA Androgenic Alopecia Therapeutics Market Y-o-Y Growth Rate by Product Type
7.8.3 MEA Androgenic Alopecia Therapeutics Market Y-o-Y Growth Rate by End User
7.9 MEA Androgenic Alopecia Therapeutics Market Share Comparison (2013-2029)
7.9.1 MEA Androgenic Alopecia Therapeutics Market Share by Region
7.9.2 MEA Androgenic Alopecia Therapeutics Market Share by Product Type
7.9.3 MEA Androgenic Alopecia Therapeutics Market Share by End User

Chapter 8 Global Androgenic Alopecia Therapeutics Market Company Profiles

8.1 Market Competition Scenario Analysis, By Company
8.2 Competitor Landscape
8.3 Company Share Analysis
8.4 Company Profiles
8.4.1 Company
8.4.1.1 Company Overview
8.4.1.2 Business Description
8.4.1.3 Product Portfolio
8.4.1.4 Key Financials
8.4.1.5 Key Developments
8.4.1.6 SWOT Analysis

Companies Included :

Johnson & Johnson
Merck
GlaxoSmithKline
Astellas Pharma
Cipla
Almirall
Sun Pharma
Reddy’s Laboratories
Concert Pharmaceuticals
RiverTown Therapeutics
Brickell Biotech
BiologicsMD
Aclaris Therapeutics

Chapter 9 Methodology and Data Source

9.1 Research Approach/ Methodology
9.2 Market Size Estimation
9.3 Market Breakdown and Data Triangulation
9.4 Data Source
9.4.1 Secondary Sources
9.4.2 Primary Sources

Androgenic Alopecia Therapeutics Industry Analysis, Market Size, Share, Trends, Growth and Forecast 2021 – 2029

Source

Recent Posts

Hair Loss Shampoos Market Growth

Management Of Hair Loss Market

Global Management Of Hair Loss Market Size, Status And Forecast 2020-2026

Management of the Hair Loss market is segmented by Type, and by Application. Players, stakeholders, and other participants in the cc

The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study

Procter & Gamble
L’Oreal
Unilever
Taisho
Henkel
Merck
Shiseido
Johnson & Johnson Consumer Inc.
Rohto
Lifes2Good
Gerolymatos International
Toppik
Nanogen
Oxford BioLabs
Ultrax Labs
Avalon Natural Products
Bayer
Pharma Medico
Wal-Mart
Kerafiber
Amplixin
Costco Wholesale
Phyto
Keranique
DS Healthcare Group
Kaminomoto
Softto
Bawang
Zhang Guang 101

Market segment by Type, the product can be split into

Hair Loss and Growth DevicesShampoos and Conditioners
Medicine Product
Others

Market segment by Application, split into

Men
Women

Market segment by Regions/Countries, this report covers

North America
Europe
China
Japan
Southeast Asia
India
Central & South America

Global Management Of Hair Loss Market Size, Status And Forecast 2020-2026

Source

Recent Posts

Global Seborrhea Drugs Market

Global Dandruff Treatment Market

Global Dandruff Treatment Market

Global Dandruff Treatment Market By Type (Dry Skin-Related Dandruff, Oily Scalp-Related Dandruff, Fungal Dandruff, Others), Shampoos Type (Normal Shampoos, Anti-Dandruff Shampoos, Dry Shampoos, Others), Medication in Shampoos (Pyrithione Zinc Shampoos, Tar-Based Shampoos, Ketoconazole Shampoos, Others), End Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy, Others), Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa) – Industry Trends and Forecast to 2026

Market Analysis: Global Dandruff Treatment Market

Global dandruff treatment market is rising gradually with a substantial in the forecast period of 2019-2026. The rise in E-commerce and the availability of multiple hair care products brings a great opportunity for growth of the market.

Market Definition: Global Dandruff Treatment Market

Dandruff is a common skin condition that is caused on the scalp. Dandruff is characterized by flaky, itchy scalp and shoes no signs of inflammation. Dandruff and seborrheic dermatitis are often assumed as similar conditions. c Anti-dandruff shampoos are majorly used for the treatment of dandruff.

Dandruff has a high prevalence rate and it affects half of the total adult population. The occurrence of dandruff minimizes with age. An estimated 1-3% adults are diagnosed by seborrheic dermatitis. This condition is more prevalent in males than in females.

Market Drivers

  • The increasing interest of people in using hair care products acts as a market driver
  • Availability of different kinds of products for dandruff treatment, anti-dandruff shampoos also uplifts the market growth
  • Introduction of innovative products such as herbal shampoos will boost this market growth
  • Changing lifestyle and growing urbanization will also drive the market growth

Market Restraints

  • Increasing adoption of No-Poo Campaign which is decreasing the consumption of hair care products restrains the market growth
  • Availability of various dandruff treatment substitutes in the market will also hamper the market growth
  • Use of herbal treatments and household treatments over hair care products will restrict the growth of the market

Segmentation: Global Dandruff Treatment Market

By Type

  • Dry Skin-Related Dandruff
  • Oily Scalp-Related Dandruff
  • Fungal Dandruff
  • Others

By Shampoos Type

  • Normal Shampoos
  • Anti-Dandruff Shampoos
  • Dry Shampoos
  • Others

By Medication in Shampoos

  • Pyrithione Zinc Shampoos
  • Tar-Based Shampoos
  • Ketoconazole Shampoos
  • Others

By End Users

  • Hospitals
  • Homecare
  • Specialty Clinics
  • Others

By Distribution Channels

  • Hospital Pharmacy
  • Online Pharmacy
  • Retail Pharmacy
  • Others

By Geography

  • North America
    • U.S.
    • Canada
    • Mexico
  • South America
    • Brazil
    • Rest of South America
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Turkey
    • Belgium
    • Netherlands
    • Switzerland
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • South Korea
    • India
    • Australia
    • Singapore
    • Thailand
    • Malaysia
    • Indonesia
    • Philippines
    • Rest of Asia Pacific
  • Middle East & Africa
    • South Africa
    • Rest of Middle East & Africa

Key Developments in the Market:

  • In October 2019, Alliance Pharma PLC received the exclusive marketing right of Nizoral, a product of Johnson & Johnson Services, Inc. used for the treatment of dandruff. The deal includes the acquisition of exclusive market rights of Nizoral in the Asia-Pacific region. This agreement will give a hike to promote the product and increase the business size of both the companies
  • In April 2019, Integumen Plc launched Labskin platform for testing new drugs and cosmetics for dandruff. This novel platform is a simulated human skin designed to be used by many pharmaceutical and cosmetic companies for evaluation and determination of safety, efficacy and any unknown effect of their products for dandruff treatment

Competitive Analysis:

Global dandruff treatment market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of dandruff treatment market for Global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.

Key Market Players:

Few of the major competitors currently working in the global dandruff treatment market are Alliance Pharma PLC, Kramer Laboratories, Integumen Plc, Avista Capital Partners, Dana Limited, STADA Arzrneimittel AG, Vibcare Pharma Pvt. Ltd, Cipla Inc., Glenmark Pharmaceuticals., Sphere Pharmaceuticals Private Limited, Johnson & Johnson Services, Inc., Unilever, TORQUE PHARMACEUTICALS PVT. LTD., SARP PHARMACEUTICALS PVT. LTD., Vyome Therapeutics Inc., TRIO LIFESCIENCE PVT.LTD., Dabur India Limited among others.

Research Methodology: Global Dandruff Treatment Market

Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analysed and forecasted using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Primary Respondents

Demand Side: Doctors, Surgeons, Medical Consultants, Nurses, Hospital Buyers, Group Purchasing Organizations, Associations, Insurers, Medical Payers, Healthcare Authorities, Universities, Technological Writers, Scientists, Promoters, and Investors among others.

Supply Side: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence, and Regulatory Affairs Managers among others.

Reasons to Purchase this Report

  • Current and future of global dandruff treatment market outlook in the developed and emerging markets
  • The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period
  • Regions/Countries that are expected to witness the fastest growth rates during the forecast period
  • The latest developments, market shares, and strategies that are employed by the major market players

Global Androgenic Alopecia Drug Market

Source

Recent Posts

Thinning Hair and Hair Loss Product Market

Global Hair Loss Prevention and Growth Product for Men

Global Hair Loss Prevention and Growth Product for Men Market Growth 2020-2025

According to this study, over the next five years, the Hair Loss Prevention and Growth Product for Men market will register a XX%% CAGR in terms of revenue, the global market size will reach $ XX million by 2025, from $ XX million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Hair Loss Prevention and Growth Product for Men business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Hair Loss Prevention and Growth Product for Men market by product type, application, key manufacturers and key regions and countries.

This study especially analyses the impact of Covid-19 outbreak on the Hair Loss Prevention and Growth Product for Men, covering the supply chain analysis, impact assessment to the Hair Loss Prevention and Growth Product for Men market size growth rate in several scenarios, and the measures to be undertaken by Hair Loss Prevention and Growth Product for Men companies in response to the COVID-19 epidemic.

Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.

Shampoos
Conditioners
Serums
Others

Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.

Supermarkets and Hypermarkets
Convenience Stores
Specialty Stores
Online
Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.

The Procter and Gamble Company
Forest Essentials
L?oreal
Kao Corporation
Shiseido Company
Unilever
Rohto Pharmaceutical
Taisho Pharmaceutical Holdings
Church and Dwight
Johnson and Johnson
Artnatural
Hain Celestial
Natura and Co
Vital?s International Group

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives

To study and analyze the global Hair Loss Prevention and Growth Product for Men consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Hair Loss Prevention and Growth Product for Men market by identifying its various subsegments.
Focuses on the key global Hair Loss Prevention and Growth Product for Men manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Hair Loss Prevention and Growth Product for Men with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Hair Loss Prevention and Growth Product for Men submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

Global Hair Loss Prevention and Growth Product for Men Market Growth 2020-2025

Source

Recent Posts

Global Hair Loss Supplement Market

Hair Loss Supplement Market Insights

Hair Loss Supplement Market Insights 2020, Global and Chinese Analysis and Forecast to 2024

Hair Loss Supplement Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Hair Loss Supplement industry with a focus on the Chinese market.

The report provides key statistics on the market status of the Hair Loss Supplement manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry.

Overall, the report provides an in-depth insight of 2014-2024 global and Chinese Hair Loss Supplement market covering all important parameters.

The key points of the report:

1. The report provides a basic overview of the industry including its definition, applications and manufacturing technology.
2. The report explores the international and Chinese major industry players in detail. In this part, the report presents the company profile, product specifications, capacity, production value, and 2014-2019 market shares for each company.
3. Through the statistical analysis, the report depicts the global and Chinese total market of Hair Loss Supplement industry including capacity, production, production value, cost/profit, supply/demand and Chinese import/export.
4. The total market is further divided by company, by country, and by application/type for the competitive landscape analysis.
5. The report then estimates 2019-2024 market development trends of Hair Loss Supplement industry. Analysis of upstream raw materials, downstream demand and current market dynamics is also carried out.
6. The report makes some important proposals for a new project of Hair Loss Supplement Industry before evaluating its feasibility.

There are 3 key segments covered in this report: competitor segment, product type segment, end use/application segment.

For competitor segment, the report includes global key players of Hair Loss Supplement as well as some small players. At least 4 companies are included:

* Nutrafol(US)
* Komplete Balance(US)
* ArtNaturals(US)
* Lia Wellness

The information for each competitor includes:

* Company Profile
* Main Business Information
* SWOT Analysis
* Sales, Revenue, Price and Gross Margin
* Market Share

For product type segment, this report listed main product type of Hair Loss Supplement market in gloabal and china.

* Tablets
* Capsules
* Others

For end use/application segment, this report focuses on the status and outlook for key applications. End users sre also listed.

* Individuals
* Clinics
* Others

Reasons to Purchase this Report:

* Estimates 2019-2024 Hair Loss Supplement market development trends with the recent trends and SWOT analysis
* Market dynamics scenario, along with growth opportunities of the market in the years to come
* Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
* Regional and country-level analysis integrating the demand and supply forces that are influencing the growth of the market.
* Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
* Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
* Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
* 1-year analyst support, along with the data support in excel format.

Hair Loss Supplement Market Insights 2020, Global and Chinese Analysis and Forecast to 2024

Source

Recent Posts

Global Hair Serum for Hair Loss Industry Market Research

Global Hair Care Products

Global Hair Care Products Market Research Report

Haircare products are used to maintain hygiene and treat hair-related issues. The main function of hair care products is to clean the dirt, dandruff, and oil from the hair and scalp, treat damaged hair, and maintain the moisture content.

Generally, hair care products are produced by combining a surfactant, such as sodium lauryl sulfate or sodium Laureth sulfate, with a co-surfactant such as Cocamidopropyl betaine in water.

Speciality hair care products are also available in the market for various hair-related concerns such as dandruff, colour-treated hair, hair fall, split ends, and dry, damaged hair.

Prominent players in the market are focusing on product innovation by offering more innovative products to consumers to cater to different hair-related concerns. Therefore, the global Hair Care Products Market is expected to witness high growth during the forecast period.

Segmentation

The global hair care products market has been segmented based on type, distribution channel, and region.

By type, the global hair care products market has been classified as shampoo, conditioner, hair oil, and others. The shampoo segment is expected to hold the majority market share and register the highest CAGR during the review period.

The global hair care products market has also been divided, on the basis of the distribution channel, into store-based and non-store-based. The store-based segment is further segmented into supermarkets and hypermarkets, convenience stores, and others. The store-based segment is expected to account for the larger revenue share of the market. However, the non-store-based segment is expected to exhibit a high growth rate during the forecast period, 2019 to 2024.

The global hair care products market has been segmented into four key regions, namely, North America, Europe, Asia-Pacific, and the rest of the world.

The hair care products market in North America has further been segmented into the US, Canada, and Mexico. The hair care products market in Europe has been classified into the UK, Germany, France, Italy, Spain, and the rest of Europe. The hair care products market in Asia-Pacific has been segmented into China, India, Japan, Australia and New Zealand, and the rest of Asia-Pacific. The hair care products market in the rest of the world has been segmented into South America, the Middle East, and Africa.

Key Players

Unilever PLC (UK), Henkel AG & Company, KGaA (Germany), The Procter & Gamble Company (US), Church & Dwight Co., Inc. (US), Kimberly-Clark Corporation (US), Kao Corporation (Japan), Beiersdorf AG (Germany), Shiseido Company, Limited (Japan), L’Oréal S.A. (France), Vogue International LLC (US), Natura (Brazil) International B.V. (Brazil), BBLUNT (India), VLCC Healthcare Limited (India), Forest Essentials (India) and Johnson & Johnson Services, Inc (US) are some of the key players operating in the global hair care products market.

Regional Market Summary

Global Hair Care Products Market Share (%), by Region, 2018

Asia-Pacific is expected to dominate the global hair care products market during the forecast period due to the growing hair-related concerns and the growing demand for innovative products. This enables brands to launch products according to the requirement of the consumers. The market in North America is projected to register the highest growth rate during the forecast period owing to the high per capita disposable incomes and increasing consumer spending on new and innovative hair care products in the region.

Global Hair Care Products Market, by Type

  • Shampoo
  • Conditioner
  • Hair Oil
  • Others

Global Hair Care Products Market, by Distribution Channel

  • Store-Based
    • Supermarkets and Hypermarkets
    • Convenience Stores
    • Others
  • Non-Store-Based

Global Hair Care Products Market, by Region

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • Italy
    • Spain
    • UK
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia and New Zealand
    • Rest of Asia-Pacific
  • Rest of the World (RoW)
    • South America
    • Middle East
    • Africa

Intended Audience

  • Personal care product manufacturers
  • Cosmetics manufacturers
  • Personal care retail outlets
  • Raw material suppliers and distributors
  • Traders, exporters, and importers

Global Hair Care Products Market Research Report

Source

Recent Posts

Global Hair Loss Supplement Market Research Report 2018

Hair Loss Supplement Market

Hair Loss Supplement Market Research: Global Status & Forecast by Geography, Type & Application (2016-2026)

According to 99Strategy, the Global Hair Loss Supplement Market is estimated to reach xxx million USD in 2020 and projected to grow at the CAGR of xx% during 2021-2026. The report analyses the global Hair Loss Supplement market, the market size and growth, as well as the major market participants.

The analysis includes market size, upstream situation, market segmentation, market segmentation, price & cost and industry environment. In addition, the report outlines the factors driving industry growth and the description of market channels.

The report begins from an overview of industry chain structure and describes the upstream. Besides, the report analyses market size and forecast in different geographies, type and end-use segment, in addition, the report introduces market competition overview among the major companies and companies profiles, besides, market price and channel features are covered in the report.

Key Regions

Asia Pacific
North America
Europe
South America
Middle East & Africa

Key Companies

Nutrafol(US)
Komplete Balance(US)
ArtNaturals(US)
Lia Wellness, Inc.(US)
BioProsper Labs(US)
Naturenetics Inc.(US)
Nature’s Wellness(US)
Nourish Beaute(US)
Pure Results Nutrition(US)

Key Product Type

Tablets
Capsules
Others

Market by Application

Individuals
Clinics
Others

Main Aspects covered in the Report

Overview of the Hair Loss Supplement market including production, consumption, status & forecast and market growth
2016-2020 historical data and 2021-2026 market forecast
Geographical analysis including major countries
Overview of the product type market including development
Overview of the end-user market including development
Impact of Coronavirus on the Industry

Hair Loss Supplement Market Research: Global Status & Forecast by Geography, Type & Application (2016-2026)

Source

Previous Posts

Kerastem and Stem Cell Hair Growth Technology

Kerastem Successful US Phase 2 Hair Growth Clinical Trial

Kerastem Publishes Successful US Phase 2 Hair Growth Clinical Trial Results

Positive results from Kerastem’s Phase 2 clinical trial in early-stage hair loss patients, known as the STYLE study, were published in the Aesthetic Surgery Journal (https://doi.org/10.1093/asj/sjaa037).

The STYLE study evaluated the effect of Puregraft purified fat + Adipose Derived Regenerative Cells (ADRCs) in different doses in a single procedure.

Patients were followed up to 1-year. In men with early-stage hair loss, the investigators reported a statistically significant increase in mean terminal (mature) hair count in men who received Puregraft fat + a low dose of ADRCs when compared to the control group at 6-months. Based on the positive results, Kerastem plans to move the technology forward in a phase 3 clinical trial.

Kerastem therapy is a one-time treatment that delivers adipose (fat) derived regenerative cells combined with purified fat to the affected area of the scalp. The Phase 2 trial was a U.S. 70 patient, multi-centre, randomized, single-blinded, and controlled clinical trial to assess the safety, tolerability, dosing and hair counts in patients with early hair loss.

“Our Phase 2 study showed the Kerastem treatment stimulates hair growth in early stage male hair loss,” said Bran Conlan, CEO of Kerastem. “If our Phase 3 trial is successful, more than 40 million people in the United States with early stage hair loss would have a new option.

STUDY RESULTS

  • Low dose Adipose Derived Regenerative Cells (ADRCs) + Puregraft fat treatment group achieved a statistically significant increase in mean terminal hair count, at 6 months, when compared to control, in males with early (Grade III) stage hair loss relative to control, an average increase of 29 terminal (mature) hairs per cm2 of scalp was observed, corresponding to a 17% increase (p < 0.05).
  • All treatment arms of STYLE were safe with no serious adverse events reported.

“STYLE indicates that the dosing of this autologous cell product and tissue preparation can play a role in achieving a successful outcome,” explained Principal Investigator Ken Washenik, M.D., Ph.D., Clinical Assistant Professor in the Ronald O. Perelman Department of Dermatology, NYU School of Medicine & Medical Director, Bosley Medical Group. “To identify the optimal procedure, we designed STYLE to evaluate controls with and without the addition of autologous fat as well as both high and lower doses of ADRCs doses and determined that 500,000 cells per square centimeter resulted in a superior outcome. In short, dose matters.”

Kerastem’s planned Phase 3 trial will support a Pre-Market Approval (PMA) filing in the United States for males with early hair loss. The company will also explore other product pipeline expansion opportunities including the Kerastem treatment for females with patterned hair loss.

ANDROGENETIC ALOPECIA MARKET SIZE

Hair loss affects more than 40 million men and over 21 million women and in the United States alone. The global hair loss treatment market generates more than $7 Billion annually and currently has limited options for men and women with early stage hair loss.

ABOUT KERASTEM

Kerastem is the leader in the development and commercialization of cell-based approaches to hair growth. The company is a wholly owned subsidiary of Bimini Health Tech. The Bimini portfolio also includes Puregraft, the world’s leading fat transfer solution.Kerastem Publishes Successful US Phase 2 Hair Growth Clinical Trial Results

Source

Previous Posts

Global Seborrhea Drugs Market

Study on Anti-Dandruff Shampoos

Global Market Study on Anti-Dandruff Shampoos

Increasing E-Commerce of Hair Care Products to Fuel Sales

There is an increasing demand for hair care products globally as these are one of the most basic products in day-to-day life. Introduction of E-commerce platforms has greatly benefitted consumers who buy general personal care and cosmetics products. E-commerce sites provide hair care products at discounted prices to customers, which result in higher sales.

Apart from this, these ensure easy availability of different kinds of shampoos such as normal shampoos, anti-dandruff shampoos, dry shampoos, etc. to customers in no time. In addition to this, online websites also offer customers various options to choose from different brands of shampoos, anti-dandruff shampoos and also specific targeted shampoos for scalp problem, dandruff, etc.

Rising E-commerce will expedite the growth of the global anti-dandruff shampoos market.

Increasing Number of Strategic M&A to Boost Market Growth

Multiple manufacturers in the anti-dandruff shampoos market are entering into various strategic alliances and collaborations to enhance their product footprint in different regions. For example, in June 2018, Kramer Laboratories announced the acquisition of Nizoral from Janssen Pharmaceutica NV.

Similarly, in April 2019, Unilever announced the acquisition of Garancia. Such strategic alliances between companies will enhance core business operations, as well as increase the worldwide availability of products.

Moreover, the company can also increase product sales by establishing different manufacturing sites and acquiring companies. Rising number of mergers and acquisitions will significantly increase the growth of the anti-dandruff shampoos market.

Growing Usage of Pyrithione Zinc in Anti-Dandruff Shampoos to Support Market Growth

Pyrithione zinc is the most widely-used active ingredient in anti-dandruff shampoos since it contains bacterial and fungal properties. Pyrithione zinc helps in preventing dandruff and other scalp problems such as seborrheic dermatitis.

In addition to this, pyrithione zinc also helps to improve hair texture. Manufacturers are currently developing anti-dandruff shampoos by using pyrithione zinc as an active ingredient. For example, some of the shampoos that contain pyrithione zinc are Coconut Anti-dandruff 2-in-1 Shampoo by Procter & Gamble and 3D Men Anti-Dandruff Shampoo by Henkel Corporation. Not only for preventing dandruff but pyrithione zinc is also used for the treatment of seborrhoeic dermatitis.

Thus, pyrithione zinc is in high demand in the production of anti-dandruff shampoos, which is likely to propel the growth of the global anti-dandruff shampoos market.

Rising Hair Problems Driving Preference for Anti-Dandruff Shampoos

Dandruff is one of the most common scalp problems all over the world. Various hair problems occur due to increasing global air pollution. People across the world use various natural remedies and anti-dandruff shampoos to prevent dandruff. Anti-dandruff shampoos are most widely used to control dandruff.

In addition to these, certain therapeutic shampoos are also in high demand and prescribed by healthcare professionals as they contain unique anti-dandruff formulations. This is expected to influence the type of products preferred by consumers.

Thus, multiple small-sized and medium-sized manufacturers develop different anti-dandruff shampoos and market them through different brands globally. With rising hair problems, new age anti-dandruff shampoos will offer consumers multiple benefits such as better hair texture, scalp care, hair fall reduction, etc., which is expected to propel the growth of the global anti-dandruff shampoos market.

Increasing Adoption of No-Poo Campaign Likely to Impact Anti-Dandruff Shampoos Market

No Poo is gaining much interest among the population globally. It is a method whereby people used natural ingredients instead of anti-dandruff shampoos for washing their hair. In this method, people avoid using anti-dandruff shampoos and prefer to use only natural products such as apple cider vinegar, baking soda, and water. This method is quite popular and such campaigns are increasing among the youth by means of media and social networking,

Since it has no side effects as compared to anti-dandruff shampoos. With rising adoption of this method, the anti-dandruff shampoos market may have considerable impact in coming years.

Global Anti-Dandruff Shampoos Market – Competition Insights

The competition section of the anti-dandruff shampoos market provides detailed information about key players competing in the anti-dandruff shampoos market based on their market shares, market strategies, product offerings, marketing approach, and company dashboard.

Some of the key players featured in this anti-dandruff shampoos market report include

  • Procter & Gamble Company
  • Unilever PLC
  • Johnson & Johnson Consumer Inc.
  • Kramer Laboratories Inc.
  • Loreal Group
  • Neoteric Cosmetics Inc.
  • Mediceuticals Laboratories
  • Hain Celestial Group
  • DS Healthcare Group Inc
  • Henkel AG & Co. KgaA.

Global Market Study on Anti-Dandruff Shampoos

Previous Posts